Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
126.62(c) 127.05(c) 127.49(c) 127.44(c) 126.93 Last
5 810 983 4 197 394 4 803 163 3 317 341 3 604 888 Volume
-1.69% +0.34% +0.35% -0.04% -0.40% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 39 807 M - -
Net income 2021 5 837 M - -
Net Debt 2021 8 454 M - -
P/E ratio 2021 38,6x
Yield 2021 1,34%
Sales 2022 39 547 M - -
Net income 2022 6 412 M - -
Net Debt 2022 6 281 M - -
P/E ratio 2022 35,4x
Yield 2022 1,43%
Capitalization 226 B 226 B -
EV / Sales 2021 5,89x
EV / Sales 2022 5,87x
Nbr of Employees 109 000
Free-Float 88,8%
More Financials
Company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,... 
More about the company
Ratings of Abbott Laboratories
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about ABBOTT LABORATORIES
09/15ABBOTT LABORATORIES : to Pay Quarterly Cash Dividend of $0.45 a Share on Nov. 15..
MT
09/15ABBOTT : Declares 391st Consecutive Quarterly Dividend
PR
09/15Abbott Laboratories Declares Quarterly Dividend, Payable on November 15, 2021
CI
09/13GLOBAL MARKETS LIVE : Valneva, Walt Disney, ViacomCBS, General Motors, Amazon...
09/13INSIDER SELL : Abbott Laboratories
MT
09/10QIAGEN N : 3M, Qiagen to comply with Biden's COVID-19 vaccination, test mandate
RE
09/10QIAGEN N : supports White House COVID-19 vaccination, test mandate
RE
09/08INSIDER SELL : Abbott Laboratories
MT
09/03INSIDER SELL : Abbott Laboratories
MT
09/02ABBOTT LABORATORIES : Acquires Medical Device Company Walk Vascular
MT
09/02ABBOTT : Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular..
PR
09/02Abbott Laboratories acquired Walk Vascular L.L.C.
CI
09/01ABBOTT LABORATORIES : BY-LAWS OF ABBOTT LABORATORIES (Form 8-K)
PU
09/01ABBOTT LABORATORIES : Change in Directors or Principal Officers, Amendments to A..
AQ
09/01Abbott Laboratories Names Patricia P. Gonzalez as Board of Directors
CI
More news
News in other languages on ABBOTT LABORATORIES
09/15Les Laboratoires Abbott déclarent un dividende trimestriel, payable le 15 nov..
09/13MADRID STOCK EXCHANGE : Los mercados se quedan sin combustible
09/13STOCK MARKET PARIS : Des marchés en panne de carburant
09/13EN DIRECT DES MARCHES : Orange, Dassault Aviation, Valneva, Alibaba, Disney, App..
09/07Pharma-Industrie geht von ausreichend Corona-Impfstoff für alle aus
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Stock Trading Strategies
ABBOTT LABORATORIES - 01/20
Close to a key resistance level
BUY
More Stock Trading Analysis
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 127,44 $
Average target price 130,04 $
Spread / Average Target 2,04%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES16.39%225 928
MEDTRONIC PLC11.76%176 193
BECTON, DICKINSON AND COMPANY4.98%75 436
HOYA CORPORATION30.10%63 907
ALIGN TECHNOLOGY, INC.36.29%57 543
SARTORIUS STEDIM BIOTECH81.73%57 390